167 related articles for article (PubMed ID: 34130846)
21. LI-RADS
Chernyak V; Santillan CS; Papadatos D; Sirlin CB
Abdom Radiol (NY); 2018 Jan; 43(1):111-126. PubMed ID: 28695233
[TBL] [Abstract][Full Text] [Related]
22. Hepatocellular Carcinoma Assessment after Locoregional Treatment: A Primer on LI-RADS Contrast-Enhanced Nonradiation Treatment Response Assessment Version 2024.
Milot L
Radiology; 2024 May; 311(2):e240124. PubMed ID: 38805731
[No Abstract] [Full Text] [Related]
23. LI-RADS categories: concepts, definitions, and criteria.
Santillan C; Chernyak V; Sirlin C
Abdom Radiol (NY); 2018 Jan; 43(1):101-110. PubMed ID: 29038857
[TBL] [Abstract][Full Text] [Related]
24. LI-RADS 2017: An update.
Kielar AZ; Chernyak V; Bashir MR; Do RK; Fowler KJ; Mitchell DG; Cerny M; Elsayes KM; Santillan C; Kamaya A; Kono Y; Sirlin CB; Tang A
J Magn Reson Imaging; 2018 Jun; 47(6):1459-1474. PubMed ID: 29626376
[TBL] [Abstract][Full Text] [Related]
25. LI-RADS M (LR-M): definite or probable malignancy, not specific for hepatocellular carcinoma.
Fowler KJ; Potretzke TA; Hope TA; Costa EA; Wilson SR
Abdom Radiol (NY); 2018 Jan; 43(1):149-157. PubMed ID: 28580538
[TBL] [Abstract][Full Text] [Related]
26. Update on the Liver Imaging Reporting and Data System: What the Pathologist Needs to Know.
Tang A; Valasek MA; Sirlin CB
Adv Anat Pathol; 2015 Sep; 22(5):314-22. PubMed ID: 26262514
[TBL] [Abstract][Full Text] [Related]
27. Imaging Diagnosis of Hepatocellular Carcinoma: The Liver Imaging Reporting and Data System, Why and How?
Cunha GM; Fowler KJ; Abushamat F; Sirlin CB; Kono Y
Clin Liver Dis; 2020 Nov; 24(4):623-636. PubMed ID: 33012449
[TBL] [Abstract][Full Text] [Related]
28. Critical review of HCC imaging in the multidisciplinary setting: treatment allocation and evaluation of response.
Amorim J; França M; Perez-Girbes A; Torregrosa A; Martí-Bonmatí L
Abdom Radiol (NY); 2020 Oct; 45(10):3119-3128. PubMed ID: 32173774
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.
Schellhaas B; Görtz RS; Pfeifer L; Kielisch C; Neurath MF; Strobel D
Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1036-1044. PubMed ID: 28562394
[TBL] [Abstract][Full Text] [Related]
30. LI-RADS
Chernyak V; Tang A; Flusberg M; Papadatos D; Bijan B; Kono Y; Santillan C
Abdom Radiol (NY); 2018 Jan; 43(1):82-100. PubMed ID: 28647768
[TBL] [Abstract][Full Text] [Related]
31. Implementation of LI-RADS into a radiological practice.
Siedlikowski ST; Kielar AZ; Ormsby EL; Bijan B; Kagay C
Abdom Radiol (NY); 2018 Jan; 43(1):179-184. PubMed ID: 28634619
[TBL] [Abstract][Full Text] [Related]
32. Multimodality Imaging of Hepatocellular Carcinoma: From Diagnosis to Treatment Response Assessment in Everyday Clinical Practice.
Delli Pizzi A; Mastrodicasa D; Cianci R; Serafini FL; Mincuzzi E; Di Fabio F; Giammarino A; Mannetta G; Basilico R; Caulo M
Can Assoc Radiol J; 2021 Nov; 72(4):714-727. PubMed ID: 32436394
[TBL] [Abstract][Full Text] [Related]
33. Reproducibility of LI-RADS treatment response algorithm for hepatocellular carcinoma after locoregional therapy.
Abdel Razek AAK; El-Serougy LG; Saleh GA; Shabana W; Abd El-Wahab R
Diagn Interv Imaging; 2020 Sep; 101(9):547-553. PubMed ID: 32253141
[TBL] [Abstract][Full Text] [Related]
34. LI-RADS treatment response categorization on gadoxetic acid-enhanced MRI: diagnostic performance compared to mRECIST and added value of ancillary features.
Kim SW; Joo I; Kim HC; Ahn SJ; Kang HJ; Jeon SK; Lee JM
Eur Radiol; 2020 May; 30(5):2861-2870. PubMed ID: 32006170
[TBL] [Abstract][Full Text] [Related]
35. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
[TBL] [Abstract][Full Text] [Related]
36. Computer-aided diagnosis program for classifying the risk of hepatocellular carcinoma on MR images following liver imaging reporting and data system (LI-RADS).
Kim Y; Furlan A; Borhani AA; Bae KT
J Magn Reson Imaging; 2018 Mar; 47(3):710-722. PubMed ID: 28556283
[TBL] [Abstract][Full Text] [Related]
37. LI-RADS-CEUS - Proposal for a Contrast-Enhanced Ultrasound Algorithm for the Diagnosis of Hepatocellular Carcinoma in High-Risk Populations.
Schellhaas B; Wildner D; Pfeifer L; Goertz RS; Hagel A; Neurath MF; Strobel D
Ultraschall Med; 2016 Dec; 37(6):627-634. PubMed ID: 27486793
[No Abstract] [Full Text] [Related]
38. Liver Imaging Reporting and Data System (LI-RADS) v2018: Review of the CT/MRI Diagnostic Categories.
Kanmaniraja D; Dellacerra G; Holder J; Erlichman D; Chernyak V
Can Assoc Radiol J; 2021 Feb; 72(1):142-149. PubMed ID: 32063008
[TBL] [Abstract][Full Text] [Related]
39. Accuracy of the diagnostic evaluation of hepatocellular carcinoma with LI-RADS.
Liu W; Qin J; Guo R; Xie S; Jiang H; Wang X; Kang Z; Wang J; Shan H
Acta Radiol; 2018 Feb; 59(2):140-146. PubMed ID: 28648125
[TBL] [Abstract][Full Text] [Related]
40. Accuracy of the Liver Imaging Reporting and Data System in Computed Tomography and Magnetic Resonance Image Analysis of Hepatocellular Carcinoma or Overall Malignancy-A Systematic Review.
van der Pol CB; Lim CS; Sirlin CB; McGrath TA; Salameh JP; Bashir MR; Tang A; Singal AG; Costa AF; Fowler K; McInnes MDF
Gastroenterology; 2019 Mar; 156(4):976-986. PubMed ID: 30445016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
